A Phase I-Ii Trial Of Da-Epoch-R Plus Ixazomib As Frontline Therapy For Patients With Myc-Aberrant Lymphoid Malignancies: The Daciphor Regimen

BLOOD(2020)

引用 3|浏览67
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要